Aquestive therapeutics reports third quarter 2022 financial results and provides business update

Warren, n.j., nov. 01, 2022 (globe newswire) -- aquestive therapeutics, inc. (nasdaq: aqst), a pharmaceutical company advancing current standards of care to solve patients' problems through simplifying complex delivery methods, today reported financial results for the third quarter ended september 30, 2022 and provided an update on recent developments in its business.
AQST Ratings Summary
AQST Quant Ranking